申请人:Alvaro Giuseppe
公开号:US20050176715A1
公开(公告)日:2005-08-11
The present invention relates to piperidine derivatives of formula (I):
R represents halogen or C
1-4
alkyl
R
1
represents C
1-4
alkyl;
R
2
or R
3
independently represent hydrogen or C
1-4
alkyl;
R
4
represents trifluoromethyl, C
1-4
alkyl, C
1-4
alkoxy, trifluoromethoxy or halogen;
R
5
represents hydrogen, C
1-4
alkyl or C
3-7
cycloalkyl;
R
6
is hydrogen and R
7
is a radical of formula (W):
or R
6
is a radical of formula (W) and R
7
is hydrogen;
X represents CH
2
, NR
5
or O; Y represents Nitrogen and Z is CH or Y represents CH and Z is Nitrogen;
A represents C(O) or S(O)q, provided that when Y is nitrogen and Z is CH, A is not S(O)
q
; m is zero or an integer from 1 to 3; n is an integer from 1 to 3; p and q are independently an integer from 1 to 2; and pharmaceutically acceptable salts and solvates thereof. The process for their preparation and their use in the treatment of a condition mediated by tachykinins.
本发明涉及式(I)的哌啶衍生物:其中,R代表卤素或C1-4烷基,R1代表C1-4烷基,R2或R3独立地代表氢或C1-4烷基,R4代表三氟甲基、C1-4烷基、C1-4烷氧基、三氟甲氧基或卤素,R5代表氢、C1-4烷基或C3-7环烷基,R6为氢,R7为式(W)的基团;或者R6为式(W)的基团,R7为氢;X代表CH2、NR5或O;Y代表氮,Z为CH或Y代表CH,Z为氮;A代表C(O)或S(O)q,但当Y为氮且Z为CH时,A不是S(O)q;m为零或1至3的整数;n为1至3的整数;p和q独立地为1至2的整数;以及其药学上可接受的盐和溶剂化物。其制备过程及其在治疗由速激肽介导的疾病中的应用。